In this section, Ana Franceschi, MD, and Paul Schulz, MD, focus on three patient cases in which PET imaging has supported a diagnosis. The first case involves a patient with non-specific cognitive impairment where FDG PET and amyloid PET are used to confirm AD pathology and a diagnosis of AD dementia. In the second case, comprehensive PET imaging (FDG, amyloid, tau) helps to provide an etiologic diagnosis of mild cognitive impairment due to AD in a patient with mild clinical symptoms. The final case illustrates how PET imaging is used to exclude a diagnosis of AD in a patient with behavioral-variant frontotemporal dementia. The section concludes with a brief summary before Tammie Benzinger, MD, PhD, provides her expert insights on the cases.
Disclosure: All panelists received honoraria from Biogen for participation in this symposium.
Disclaimer: All of the information discussed today is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.